Radin DP, Zhong S, Cerne R, Shoaib M, Smith JL, Witkin J, Lippa A. Preclinical Pharmacology of CX1837, a High-Impact Ampakine with an Improved Safety Margin: Implications for Treating Alzheimer's Disease and Ischemic Stroke. Curr Alzheimer Res. 2025 Feb 10; Epub 2025 Feb 10 PubMed.
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.